Pacer Advisors Inc. Increases Stock Position in Amedisys, Inc. (NASDAQ:AMED)

Pacer Advisors Inc. raised its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 11,621.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 558,197 shares of the health services provider's stock after purchasing an additional 553,435 shares during the period. Pacer Advisors Inc. owned 1.70% of Amedisys worth $50,679,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Polar Asset Management Partners Inc. purchased a new stake in Amedisys during the 3rd quarter worth approximately $28,953,000. SG Americas Securities LLC increased its position in shares of Amedisys by 413.4% during the third quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider's stock worth $18,985,000 after purchasing an additional 158,398 shares in the last quarter. Verition Fund Management LLC raised its stake in Amedisys by 608.1% in the 3rd quarter. Verition Fund Management LLC now owns 114,774 shares of the health services provider's stock valued at $11,077,000 after purchasing an additional 98,565 shares during the last quarter. Westchester Capital Management LLC lifted its holdings in Amedisys by 9.5% in the 3rd quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider's stock valued at $107,976,000 after purchasing an additional 97,476 shares in the last quarter. Finally, Oddo BHF Asset Management Sas purchased a new stake in shares of Amedisys during the third quarter worth $7,238,000. Institutional investors and hedge funds own 94.36% of the company's stock.

Amedisys Price Performance

AMED stock traded up $0.08 during mid-day trading on Friday, reaching $92.49. The company's stock had a trading volume of 203,630 shares, compared to its average volume of 310,556. The stock has a market cap of $3.03 billion, a PE ratio of 36.70, a P/E/G ratio of 1.84 and a beta of 0.72. The company's 50 day moving average is $89.37 and its two-hundred day moving average is $94.05. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). The company had revenue of $587.67 million for the quarter, compared to analysts' expectations of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.98 EPS. Equities research analysts expect that Amedisys, Inc. will post 4.43 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.